ATE475710T1 - Zusammensetzungen und verfahren für die therapie und diagnose von ovariumkrebs - Google Patents
Zusammensetzungen und verfahren für die therapie und diagnose von ovariumkrebsInfo
- Publication number
- ATE475710T1 ATE475710T1 AT99966445T AT99966445T ATE475710T1 AT E475710 T1 ATE475710 T1 AT E475710T1 AT 99966445 T AT99966445 T AT 99966445T AT 99966445 T AT99966445 T AT 99966445T AT E475710 T1 ATE475710 T1 AT E475710T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- methods
- therapy
- cancer
- diagnosis
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 201000011510 cancer Diseases 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title 1
- 206010033128 Ovarian cancer Diseases 0.000 abstract 4
- 206010061535 Ovarian neoplasm Diseases 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/828—Cancer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/85—Reproductive organs or embryos
- Y10S530/852—Sperm
- Y10S530/853—Ovary; eggs; embryos
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/216,003 US6670463B1 (en) | 1998-12-17 | 1998-12-17 | Compositions and methods for therapy of ovarian cancer |
| US09/215,681 US6528253B1 (en) | 1998-12-17 | 1998-12-17 | Compositions and methods for diagnosis of ovarian cancer |
| US09/338,933 US6488931B1 (en) | 1998-12-17 | 1999-06-23 | Compositions and methods for therapy and diagnosis of ovarian cancer |
| US09/404,879 US6468546B1 (en) | 1998-12-17 | 1999-09-24 | Compositions and methods for therapy and diagnosis of ovarian cancer |
| PCT/US1999/030270 WO2000036107A2 (en) | 1998-12-17 | 1999-12-17 | Compositions and methods for therapy and diagnosis of ovarian cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE475710T1 true ATE475710T1 (de) | 2010-08-15 |
Family
ID=26910274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99966445T ATE475710T1 (de) | 1998-12-17 | 1999-12-17 | Zusammensetzungen und verfahren für die therapie und diagnose von ovariumkrebs |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US6488931B1 (de) |
| CN (1) | CN101816788A (de) |
| AT (1) | ATE475710T1 (de) |
| DE (1) | DE69942637D1 (de) |
| NZ (2) | NZ567750A (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1109937B1 (de) | 1998-09-02 | 2008-11-05 | Diadexus, Inc. | Verfahren zur diagnose, bewertung sowie bilddarstellung verschiedener krebserkrankungen |
| ATE502051T1 (de) * | 2002-10-16 | 2011-04-15 | Purdue Pharma Lp | Antikörper, die an zellassoziiertes ca 125/0722p binden, und verfahren zu deren anwendung |
| WO2004092407A1 (en) * | 2003-04-17 | 2004-10-28 | Genesis Group Inc. | Pygopus in diagnosis and treatment of cancer |
| BRPI0620601A2 (pt) | 2005-12-08 | 2011-11-16 | Medarex Inc | anticorpo monoclonal humano isolado ou uma porção ligante ao antìgeno do mesmo, composição, imunoconjugado, molécula de ácido nucléico isolada, vetor de expressão, célula hospedeira, método para preparar um anticorpo anti-o8e e método para tratar ou prevenir uma doença definida pelo crescimento de células tumorais expressando o8e |
| CN106755406A (zh) * | 2016-12-22 | 2017-05-31 | 亚能生物技术（深圳）有限公司 | 一种卵巢癌检测产品及试剂盒 |
| AU2020307943A1 (en) * | 2019-06-28 | 2021-12-02 | Enara Bio Limited | Novel cancer antigens and methods |
| CN110499324A (zh) * | 2019-09-02 | 2019-11-26 | 中生康元生物科技(北京)有限公司 | 一种用于鉴定肿瘤新抗原的细菌表达载体及筛选鉴定肿瘤新抗原的方法 |
| CN121022684A (zh) * | 2025-10-27 | 2025-11-28 | 中国科学院杭州医学研究所 | 一种肿瘤抑制性大肠杆菌08及其用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992015612A1 (fr) * | 1991-03-04 | 1992-09-17 | Asahi Denka Kogyo K.K. | Curculine b, adn codant pour cette substance et leur production |
-
1999
- 1999-06-23 US US09/338,933 patent/US6488931B1/en not_active Expired - Fee Related
- 1999-12-17 DE DE69942637T patent/DE69942637D1/de not_active Expired - Lifetime
- 1999-12-17 CN CN200810183705A patent/CN101816788A/zh active Pending
- 1999-12-17 NZ NZ567750A patent/NZ567750A/en not_active IP Right Cessation
- 1999-12-17 NZ NZ550860A patent/NZ550860A/en not_active IP Right Cessation
- 1999-12-17 AT AT99966445T patent/ATE475710T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ550860A (en) | 2008-07-31 |
| US6488931B1 (en) | 2002-12-03 |
| DE69942637D1 (de) | 2010-09-09 |
| NZ567750A (en) | 2009-12-24 |
| CN101816788A (zh) | 2010-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ512247A (en) | Compositions and methods for therapy and diagnosis of ovarian cancer | |
| ATE410446T1 (de) | Zusammensetzungen zur behandlung und diagnose von eierstockkrebs | |
| WO2001008636A8 (en) | Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein | |
| ATE209680T1 (de) | Isolierte nukleinsäuremoleküle, peptide die mit hla-a2 moleküle (mhc) komplexe bilden, sowie deren verwendungen | |
| DE60232102D1 (de) | Zusammensetzungen und Verfahren zur WT1-spezifischen Immuntherapie | |
| TR200103560T2 (tr) | Göğüs kanserinin teşhis ve tedavisi için bileşimler ve bunların kullanımı | |
| ATE299180T1 (de) | Intrazellulare domäne des her-2/neu proteins, für die prevention oder behandlung von bösartigen tumoren | |
| BR9914116A (pt) | Composições e métodos para imunoterapia especìfica de wt1 | |
| PT1157041E (pt) | Anticorpos para terapia e diagnostico de cancro | |
| DE69840868D1 (de) | Mage-3 peptide, die durch hla-klasse-ii molecule presentiert werden | |
| JPS6452800A (en) | Cytokeratine tumor marker | |
| BG101024A (bg) | Моноклонално антитяло срещу сd44v6 | |
| DE3856180D1 (de) | Nukleinsaürefragmente, die mannose bindende fragmente vom menschlichen mannosebindenden protein kodieren | |
| DE69626423D1 (de) | Verfahren und zusammensetzung zur umgestaltung multi-epitopischer antigene um die immunantwort einzuleiten | |
| WO2002078516A3 (en) | Compositions and methods for the therapy and diagnosis of cancer | |
| WO2001018046A3 (en) | Ovarian tumor sequences and methods of use therefor | |
| DE69942637D1 (de) | Zusammensetzungen und verfahren für die therapie und diagnose von ovariumkrebs | |
| ATE239035T1 (de) | Durch hla-b44 moleküle präsentierte tumor- abstossungsantigene und ihre verwendungen | |
| ES2111757T3 (es) | Regiones antigenicas de complejos de particulas liberadas por tumores (tlp) y anticuerpos contra los mismos. | |
| ES556684A0 (es) | Un procedimiento para tratar celulas efectoras que tienen receptores de superficie para la region fc de un anticuerpo | |
| PT821060E (pt) | Mutacoes de e-caderina como base para o diagnostico e a terapia de tumores humanos malignos | |
| CY1108790T1 (el) | Συνθεσεις για τη θεραπεια και διαγνωση ωοθηκικου καρκινου | |
| ATE435284T1 (de) | Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs | |
| ATE291738T1 (de) | Diagnose und behandlung von krebs unter verwendung von sgp28-ähnlichen molekülen | |
| ATE209041T1 (de) | Durch hla-b44 moleküle präsentierte tumor- abstossungsantigene und ihre verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |